These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21700258)

  • 41. Standardized Goal-Directed Valsalva Maneuver for Assessment of Inducible Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy.
    Kumar S; Van Ness G; Bender A; Yadava M; Minnier J; Ravi S; McGrath L; Song HK; Heitner SB
    J Am Soc Echocardiogr; 2018 Jul; 31(7):791-798. PubMed ID: 29573929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypertrophic cardiomyopathy with right ventricular outflow tract and left ventricular intracavitary obstruction.
    Malik R; Maron MS; Rastegar H; Pandian NG
    Echocardiography; 2014 May; 31(5):682-5. PubMed ID: 24649889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography.
    Masri A; Pierson LM; Smedira NG; Agarwal S; Lytle BW; Naji P; Thamilarasan M; Lever HM; Cho LS; Desai MY
    Am Heart J; 2015 May; 169(5):684-692.e1. PubMed ID: 25965716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy.
    Lu DY; Hailesealassie B; Ventoulis I; Liu H; Liang HY; Nowbar A; Pozios I; Canepa M; Cresswell K; Luo HC; Abraham MR; Abraham TP
    Int J Cardiol; 2017 Sep; 243():290-295. PubMed ID: 28747034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of left ventricular outflow tract area after septal reduction in obstructive hypertrophic cardiomyopathy: a real-time 3-dimensional echocardiographic study.
    Sitges M; Qin JX; Lever HM; Bauer F; Drinko JK; Agler DA; Kapadia SR; Tuzcu EM; Smedira NG; Lytle BW; Thomas JD; Shiota T
    Am Heart J; 2005 Oct; 150(4):852-8. PubMed ID: 16209993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alcohol septal ablation after transaortic valve implantation: the dynamic nature of left outflow tract obstruction.
    Sorajja P; Booker JD; Rihal CS
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):387-91. PubMed ID: 22311437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postprandial Hemodynamics in Hypertrophic Cardiomyopathy.
    Adams JC; Bois JP; Masaki M; Yuasa T; Oh JK; Ommen SR; Nishimura RA; Klarich KW
    Echocardiography; 2015 Nov; 32(11):1614-20. PubMed ID: 26010128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of Valsalva Maneuver, Amyl Nitrite, and Exercise Echocardiography to Demonstrate Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy.
    Ayoub C; Geske JB; Larsen CM; Scott CG; Klarich KW; Pellikka PA
    Am J Cardiol; 2017 Dec; 120(12):2265-2271. PubMed ID: 29054275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imaging of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
    Stewart M; Elagizi A; Gilliland YE
    Curr Opin Cardiol; 2023 Sep; 38(5):405-414. PubMed ID: 37115813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intraoperative direct measurement of left ventricular outflow tract gradients to guide surgical myectomy for hypertrophic cardiomyopathy.
    Ashikhmina EA; Schaff HV; Ommen SR; Dearani JA; Nishimura RA; Abel MD
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):53-9. PubMed ID: 20884022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of the ingestion of ethanol on obstruction of the left ventricular outflow tract in hypertrophic cardiomyopathy.
    Paz R; Jortner R; Tunick PA; Sclarovsky S; Eilat B; Perez JL; Kronzon I
    N Engl J Med; 1996 Sep; 335(13):938-41. PubMed ID: 8782501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morphological Determinants of Obstructive Hypertrophic Cardiomyopathy Obtained Using Echocardiography.
    Nara I; Iino T; Watanabe H; Sato W; Watanabe K; Shimbo M; Umeta Y; Ito H
    Int Heart J; 2018 Mar; 59(2):339-346. PubMed ID: 29479008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The left ventricular outflow in hypertrophic cardiomyopathy: from structure to function.
    Yacoub MH; El-Hamamsy I; Said K; Magdi G; Abul Enein F; George R; Rossi A; Olivotto I; Cecchi F
    J Cardiovasc Transl Res; 2009 Dec; 2(4):510-7. PubMed ID: 20560010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Feasibility study of percutaneous transvalvular endomyocardial cryoablation for the treatment of hypertrophic obstructive cardiomyopathy.
    Keane D; Hynes B; King G; Shiels P; Brown A
    J Invasive Cardiol; 2007 Jun; 19(6):247-51. PubMed ID: 17541123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.
    Matsubara H; Nakatani S; Nagata S; Ishikura F; Katagiri Y; Ohe T; Miyatake K
    J Am Coll Cardiol; 1995 Sep; 26(3):768-75. PubMed ID: 7642872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 4D flow MRI left atrial kinetic energy in hypertrophic cardiomyopathy is associated with mitral regurgitation and left ventricular outflow tract obstruction.
    Gupta AN; Soulat G; Avery R; Allen BD; Collins JD; Choudhury L; Bonow RO; Carr J; Markl M; Elbaz MSM
    Int J Cardiovasc Imaging; 2021 Sep; 37(9):2755-2765. PubMed ID: 33523363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study.
    Sorajja P; Nishimura RA; Gersh BJ; Dearani JA; Hodge DO; Wiste HJ; Ommen SR
    J Am Coll Cardiol; 2009 Jul; 54(3):234-41. PubMed ID: 19589436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Three-dimensional haemodynamics in patients with obstructive and non-obstructive hypertrophic cardiomyopathy assessed by cardiac magnetic resonance.
    Allen BD; Choudhury L; Barker AJ; van Ooij P; Collins JD; Bonow RO; Carr JC; Markl M
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):29-36. PubMed ID: 25108915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized Trial of Metoprolol in Patients With Obstructive Hypertrophic Cardiomyopathy.
    Dybro AM; Rasmussen TB; Nielsen RR; Andersen MJ; Jensen MK; Poulsen SH
    J Am Coll Cardiol; 2021 Dec; 78(25):2505-2517. PubMed ID: 34915981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morphologic basis for obstruction to right ventricular outflow in hypertrophic cardiomyopathy.
    Maron BJ; McIntosh CL; Klues HG; Cannon RO; Roberts WC
    Am J Cardiol; 1993 May; 71(12):1089-94. PubMed ID: 8475874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.